PULSE BIOSCIENCES INC (PLSE) Stock News

NASDAQ:PLSE - US74587B1017 - Common Stock

15.14 USD

-0.03 (-0.2%)

Last: 9/5/2025, 3:14:11 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PLSE Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 days ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

9 days ago - By: Zacks Investment Research - Mentions: BSX WST MEDP

PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment

10 days ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

4 months ago - By: Benzinga - Mentions: MSC ELUT ACIW JYNT ...

Earnings Scheduled For May 8, 2025

24 days ago - By: The Motley Fool

Pulse Biosciences Cash Jumps in Q2

24 days ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

a month ago - By: Pulse Biosciences, Inc.

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

a month ago - By: Pulse Biosciences

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

24 days ago - By: Benzinga - Mentions: BKV IMCC VALN PRTS ...

Earnings Scheduled For August 12, 2025

2 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

4 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

4 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

4 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

5 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

5 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

5 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

6 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

6 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

7 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

7 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

7 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting

8 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

8 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

8 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

8 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference

9 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

9 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants

9 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery